The BRIUMVI Pregnancy Registry

Join the study to help learn about the safety of using BRIUMVI® (ublituximab-xiiy) and other multiple sclerosis medications during pregnancy.

Are you pregnant and diagnosed with multiple sclerosis?

Have you taken BRIUMVI (ublituximab-xiiy) or other multiple sclerosis medications during your pregnancy?

Multiple sclerosis can be a debilitating condition. Help future pregnant women, doctors, and researchers through this study to understand the safety of medications in pregnant women with multiple sclerosis.

I am a Patient

Are you a healthcare provider who treats pregnant women with multiple sclerosis?

Help us learn more about the safety of using BRIUMVI (ublituximab-xiiy) and other multiple sclerosis medications during pregnancy.

I am a Healthcare Provider
Pregnant woman smiling

About the BRIUMVI Pregnancy Registry

The goal of the BRIUMVI Pregnancy Registry is to help doctors, patients, and researchers better understand the safety of BRIUMVI (ublituximab-xiiy) and other multiple sclerosis medications used during pregnancy.

Pregnant women in the United States with multiple sclerosis may be eligible to participate. The study collects health information from enrolled pregnant women and their healthcare providers related to their pregnancies and developing babies up to 1 year of age.

Would you like to participate?

Register

Learn more about the Registry

I am a Patient I am a Healthcare Provider
Telephone icon

Alternatively, call the Registry Team toll free at 1-877-411-4546 (hours of operation 8.30am-5.00pm EST Monday-Friday)

Additional Information

Prescribing Information

Full Prescribing Information
and Medication Guide

Are you breastfeeding or planning to breastfeed and living with multiple sclerosis?

You may be eligible to participate in a clinical research study

Find out more
Register